Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sheehan

Showing results (271-280 of 281) with videos related to

Pageof 29
Sort By:
Annals of Neurology|March 31, 2012
Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrenceMichael Marnane, Aine Merwick, Orla C Sheehan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
Informing Patient-Centered Care Through Stakeholder Engagement and Highly Stratified Quantitative Benefit-Harm AssessmentsHélène E Aschmann, Cynthia M Boyd, Craig W Robbins, et al.
Cell|February 9, 1996
Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathwayM A Meraz, J M White, K C Sheehan, et al.
Pharmacoepidemiology and Drug Safety|April 8, 2025
Discontinuation Categories Underlying Gaps in Dispensing for Six Medication GroupsElizabeth A Bayliss, Glenn K Goodrich, Jennifer C Barrow, et al.
Trials|June 20, 2020
The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trialE A Bayliss, S M Shetterly, M L Drace, et al.
BMJ Open|September 1, 2019
Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessmentHélène E Aschmann, Cynthia M Boyd, Craig W Robbins, et al.
JAMA Internal Medicine|March 28, 2022
Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized TrialElizabeth A Bayliss, Susan M Shetterly, Melanie L Drace, et al.
Drugs & Aging|November 20, 2023
Evaluating the Safety of an Educational Deprescribing Intervention: Lessons from the Optimize TrialCynthia M Boyd, Susan M Shetterly, John D Powers, et al.
BMC Geriatrics|November 17, 2022
CELPI: trial protocol for a randomised controlled trial of a Carer End of Life Planning Intervention in people dying with dementiaG Arendts, L Chenoweth, B J Hayes, et al.
Health and Quality of Life Outcomes|December 21, 2019
Outcome preferences of older people with multiple chronic conditions and hypertension: a cross-sectional survey using best-worst scalingHélène E Aschmann, Milo A Puhan, Craig W Robbins, et al.
Pageof 29

Showing results (271-280 of 281) with videos related to

Sort By:
Pageof 29
Annals of Neurology|March 31, 2012
Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrenceMichael Marnane, Aine Merwick, Orla C Sheehan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
Informing Patient-Centered Care Through Stakeholder Engagement and Highly Stratified Quantitative Benefit-Harm AssessmentsHélène E Aschmann, Cynthia M Boyd, Craig W Robbins, et al.
Cell|February 9, 1996
Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathwayM A Meraz, J M White, K C Sheehan, et al.
Pharmacoepidemiology and Drug Safety|April 8, 2025
Discontinuation Categories Underlying Gaps in Dispensing for Six Medication GroupsElizabeth A Bayliss, Glenn K Goodrich, Jennifer C Barrow, et al.
Trials|June 20, 2020
The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trialE A Bayliss, S M Shetterly, M L Drace, et al.
BMJ Open|September 1, 2019
Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessmentHélène E Aschmann, Cynthia M Boyd, Craig W Robbins, et al.
JAMA Internal Medicine|March 28, 2022
Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized TrialElizabeth A Bayliss, Susan M Shetterly, Melanie L Drace, et al.
Drugs & Aging|November 20, 2023
Evaluating the Safety of an Educational Deprescribing Intervention: Lessons from the Optimize TrialCynthia M Boyd, Susan M Shetterly, John D Powers, et al.
BMC Geriatrics|November 17, 2022
CELPI: trial protocol for a randomised controlled trial of a Carer End of Life Planning Intervention in people dying with dementiaG Arendts, L Chenoweth, B J Hayes, et al.
Health and Quality of Life Outcomes|December 21, 2019
Outcome preferences of older people with multiple chronic conditions and hypertension: a cross-sectional survey using best-worst scalingHélène E Aschmann, Milo A Puhan, Craig W Robbins, et al.
Pageof 29